Biogen Inc forecast 2026 profit above Wall Street’s expectations, signalling that steep cost-cutting measures are cushioning ...

Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced −Highlights Phase 2 data for ATH434 in Multiple System ...

"China has found a balance in the global healthcare 'impossible triangle' of high quality, affordability, and short wait ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease ...

Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...

Seasoned clinical development leader brings more than 25 years of deep expertise in clinical development and operations across biotech and ...

The UAE is rapidly consolidating its position as a global pharmaceutical and life sciences hub, with the national market ...

After repeated efforts, California Attorney General Rob Bonta and litigators from multiple states celebrated their win in a lawsuit against the Trump administration for withholding $379 million in ...

The harrowing Turpin family case revisited—how Jordan Turpin’s daring escape exposed years of abuse and what new revelations ...

After up to three years on GA Depot, most people with PPMS have not experienced any disability progression, according to new ...

For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...